Project Grant R21HD120719
- The Children's Hospital of Philadelphia (CHOP) received a $147,037 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant supports a study to identify optimal electrophysiological markers for predicting developmental outcomes in infants. The research will examine the similarity between resting-state and auditory electroencephalography...
- This federal Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,366,365.00 to The Children's Hospital of Philadelphia (CHOP) to conduct a research study titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The study aims to advance healthcare for children by improving the understanding of brain development in those with neurofibromatosis type 1, a genetic disorder that...
- The Children's Hospital of Philadelphia (CHOP) was awarded a $160,052 Project Grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant will fund a 5-year research project led by Dr. Elizabeth (Betsy) Salazar to investigate how hospital financial health and neonatal intensive care unit (NICU) strain influence variation and disparities in neonatal outcomes, particularly for...
- This federal Project Grant award of $2,375,939.00 from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) is funding a research study on "Neural Markers of Late Language Emergence in Preschool Children Born Very and Extremely Preterm" at The Children's Hospital of Philadelphia (CHOP). The research aims to investigate the neural mechanisms underlying delayed language development in children born prematurely. The award was made on September 10,...
- The Children's Hospital of Philadelphia (CHOP) received a $732,541 Project Grant award from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310). The goal of this 24-month grant, awarded on August 7, 2025, is to develop a transdisciplinary training program to foster a new generation of investigators to pursue research in youth and adults with Down syndrome (DS). The PARTNERS program will provide a week-long in-person short course at CHOP, supplemented by...
- This federal Project Grant award, titled "Reducing Disparities in Access to High-Level Neonatal Intensive Care and Neonatal Outcomes," is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The $736,279 grant, awarded on April 15, 2025, will be used by The Children's Hospital of Philadelphia (CHOP) to conduct research aimed at determining how...
- The Children's Hospital of Philadelphia (CHOP) was awarded a $801,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research targeting "MARROW NICHE DYSREGULATION DURING STEM CELL TRANSPLANT FOR BONE MARROW FAILURE ASSOCIATED WITH MONOSOMY 7 MYELODYSPLASTIC SYNDROMES." This multi-year research project, running from September 1, 2023 to August 31, 2026, aims to investigate medical solutions...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $178,000.00 to The Children's Hospital of Philadelphia (CHOP) to design and validate a Pelizaeus Merzbacher Disease (PMD) severity scale. The goal is to develop a clinician-reported outcome measure that can be used to stratify PMD patients by disease severity, particularly early in the disease...
- The Defense Health Agency awarded a $1,746,810 Project Grant to The Children's Hospital of Philadelphia (CHOP) on July 1, 2025, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports the research project "Combination Therapy for High-Risk, MYCN-Amplified Neuroblastoma" which aims to develop innovative medical solutions to address critical health challenges for military personnel and the broader public. The research will be...
- The U.S. Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $356,000 Project Grant to The Children's Hospital of Philadelphia (CHOP) to conduct research on "INTERROGATING CELL DEATH MECHANISMS AND IDENTIFYING THERAPEUTIC LEADS IN ZERBRAFISH AND HUMAN CELL SURF1 MODELS OF LEIGH SYNDROME." The research project aims to advance understanding of the cell death mechanisms involved in Leigh syndrome, a rare neurological disorder,...
The Children's Hospital of Philadelphia (CHOP) has been awarded a $415,245 Project Grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research Federal Grant Program (CFDA 93.865). The grant will fund a natural history study and development of patient-centric clinical outcome assessments for Tubulin Beta 4A-Associated Leukodystrophy (TUBB4A-LD), a rare pediatric hypomyelinating disorder. Key objectives include mapping systemic complications of TUBB4A-LD and developing a novel quantitative measure of systemic burden to guide clinical trial readiness. This work will inform evidence-based clinical guidelines and support the design of safe, effective clinical trials for emerging TUBB4A-LD therapies. The project will be conducted over a 2-year period from Sep 2025 to Aug 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $415.2k | 8/29/25 |